Virbac (Virbac) Other Gross PPE : $42 Mil (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Virbac Other Gross PPE?

Virbac's Other Gross PPE for the quarter that ended in Jun. 2023 was $42 Mil.

Virbac's quarterly Other Gross PPE increased from Jun. 2022 ($38 Mil) to Dec. 2022 ($40 Mil) and increased from Dec. 2022 ($40 Mil) to Jun. 2023 ($42 Mil).

Virbac's annual Other Gross PPE increased from Dec. 2020 ($38 Mil) to Dec. 2021 ($38 Mil) and increased from Dec. 2021 ($38 Mil) to Dec. 2022 ($40 Mil).

Virbac Other Gross PPE Historical Data

The historical data trend for Virbac's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Other Gross PPE Chart

Virbac Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Gross PPE

Get a 7-Day Free Trial

36.63

34.29

37.61

37.72

39.83

Virbac Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Other Gross PPE	Get a 7-Day Free Trial															38.10	37.72	38.31	39.83	42.01

Virbac Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Virbac (Virbac) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (OTCPK:VRBCF) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

0NM7:UK VIRP:France V16:Germany

Address

2065m LID, 1 ere avenue, Carros, FRA, 06516

Website

https://www.virbac.com

Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America.